Search results
Nasdaq composite today: The index closed up 5.93% YTD
USA Today· 5 hours agoThe Nasdaq composite closed today at 15,840.96. The Nasdaq composite has historically had a high...
Criteo (CRTO) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 7 minutes agoImage source: The Motley Fool. Criteo (NASDAQ: CRTO) Q1 2024 Earnings Call May 02, 2024, 8:00 a.m. ET Contents: Prepared...Relations Good morning,...
Expedia Group (EXPE) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 22 minutes agoImage source: The Motley Fool. Expedia Group (NASDAQ: EXPE) Q1 2024 Earnings Call May 02, 2024, 4:30...
Dow Jones Futures Rise As Stock Market Rallies Into Jobs Report; Apple Jumps On Buyback
Investor's Business Daily· 23 minutes agoMarkets are leaning toward a first Fed rate cut in September, with a 50-50 chance of two cuts for...
Why Freshworks Stock Crashed Today
Motley Fool via Yahoo Finance· 3 hours agoFreshworks (NASDAQ: FRSH) stock plummeted in Thursday's trading. The company's share price closed out the daily session down 19.6%, according to data...
Stagwell Inc. (NASDAQ:STGW) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 12 hours agoStagwell Inc. (NASDAQ:STGW) Q1 2024 Earnings Call Transcript May 1, 2024 Stagwell Inc. reports...
Will Weakness in Synopsys, Inc.'s (NASDAQ:SNPS) Stock Prove Temporary Given Strong Fundamentals?
Simply Wall St. via Yahoo Finance· 12 hours agoSynopsys (NASDAQ:SNPS) has had a rough month with its share price down 9.5%. However, a closer look...
DraftKings (NASDAQ:DKNG) Beats Expectations in Strong Q1, Full-Year Sales Guidance Is Optimistic
StockStory via Yahoo Finance· 6 hours agoFantasy sports and betting company DraftKings (NASDAQ:DKNG) announced better-than-expected results...
Earnings call: 2U, Inc. surpasses Q1 expectations, focuses on growth
Investing.com· 5 minutes ago2U, Inc. (NASDAQ: NASDAQ: TWOU ), a leader in online education, has reported financial results for...
Earnings call: Cerus Corporation sees growth with INTERCEPT RBCs trial success
Investing.com· 9 minutes agoCerus Corporation (NASDAQ: CERS ) has announced positive outcomes from its Phase 3 ReCePI clinical...
